This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2015 Apr 14:350:h1765.

doi: 10.1136/bmj.h1765.

Relapse in multiple sclerosis

Ian Galea¹, Nicki Ward-Abel², Christoph Heesen³

Affiliations

Affiliations

¹ Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK I.Galea@soton.ac.uk.
² Birmingham City University, Edgbaston, Birmingham, UK.
³ Institute for Neuroimmunology and MS, and Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 25872511
DOI: 10.1136/bmj.h1765

Free article

Review

Relapse in multiple sclerosis

Ian Galea et al. BMJ. 2015.

Free article

. 2015 Apr 14:350:h1765.

doi: 10.1136/bmj.h1765.

Authors

Ian Galea¹, Nicki Ward-Abel², Christoph Heesen³

Affiliations

¹ Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK I.Galea@soton.ac.uk.
² Birmingham City University, Edgbaston, Birmingham, UK.
³ Institute for Neuroimmunology and MS, and Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 25872511
DOI: 10.1136/bmj.h1765

No abstract available

PubMed Disclaimer

Similar articles

[Clinical picture and therapy of multiple sclerosis].
Schrader A. Schrader A. Wien Med Wochenschr. 1972 Mar 4;122(10):129-34. Wien Med Wochenschr. 1972. PMID: 4334261 Review. German. No abstract available.
[Immunosuppressive treatment in multiple sclerosis].
Vermeulen M, Zegerius L, van Crevel H. Vermeulen M, et al. Ned Tijdschr Geneeskd. 1987 Jan 17;131(3):93-6. Ned Tijdschr Geneeskd. 1987. PMID: 3821989 Dutch. No abstract available.
[Suspected multiple sclerosis].
Pellkofer H, Hohlfeld R. Pellkofer H, et al. MMW Fortschr Med. 2006 Mar 30;148(13):63-4. MMW Fortschr Med. 2006. PMID: 16642711 German. No abstract available.
[Encephalomyelitis disseminata (also called multiple sclerosis)].
Meyer G. Meyer G. Fortschr Med. 1973 May 17;91(14):611-5. Fortschr Med. 1973. PMID: 4734084 German. No abstract available.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Narula S. Narula S. Curr Probl Pediatr Adolesc Health Care. 2016 Feb;46(2):62-9. doi: 10.1016/j.cppeds.2015.11.002. Epub 2015 Dec 5. Curr Probl Pediatr Adolesc Health Care. 2016. PMID: 26669599 Review.

See all similar articles

Cited by

The Neutrophil-to-Lymphocyte Ratio and the Monocyte-to-Lymphocyte Ratio Predict Expanded Disability Status Scale Score at One Year in Pediatric Neuromyelitis Optica Spectrum Disorder but not in Multiple Sclerosis.
Devlin L, Gombolay G. Devlin L, et al. Pediatr Neurol. 2023 Jun;143:84-88. doi: 10.1016/j.pediatrneurol.2023.03.009. Epub 2023 Mar 17. Pediatr Neurol. 2023. PMID: 37044044
Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing.
Putscher E, Hecker M, Fitzner B, Boxberger N, Schwartz M, Koczan D, Lorenz P, Zettl UK. Putscher E, et al. Front Immunol. 2022 Oct 28;13:931831. doi: 10.3389/fimmu.2022.931831. eCollection 2022. Front Immunol. 2022. PMID: 36405756 Free PMC article.
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.
Debus JL, Bachmann P, Frahm N, Mashhadiakbar P, Langhorst SE, Streckenbach B, Baldt J, Heidler F, Hecker M, Zettl UK. Debus JL, et al. Ther Adv Chronic Dis. 2022 Aug 4;13:20406223221108391. doi: 10.1177/20406223221108391. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35959503 Free PMC article.
The 27-Item Multiple Sclerosis Quality of Life Questionnaire: A New Brief Measure Including Treatment Burden and Work Life.
Beckmann H, Heesen C, Augustin M, Blome C. Beckmann H, et al. Int J MS Care. 2022 Jul-Aug;24(4):147-153. doi: 10.7224/1537-2073.2020-088. Epub 2021 Dec 7. Int J MS Care. 2022. PMID: 35875460 Free PMC article.
Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.
Chitnis T, Vandercappellen J, King M, Brichetto G. Chitnis T, et al. Neurol Ther. 2022 Sep;11(3):1043-1070. doi: 10.1007/s40120-022-00368-2. Epub 2022 Jun 9. Neurol Ther. 2022. PMID: 35680693 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

Department of Health/United Kingdom

LinkOut - more resources

Full Text Sources
Medical
- Genetic Alliance
- MedlinePlus Health Information